Yannick De Vlaeminck

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

ORCID

Google Scholar

Academic Page

Articles (16)

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

Article Link

Year:

2024

Scrutiny of chimeric antigen receptor activation by the extracellular domain

Article Link

Year:

2024

Assessment of connexin43 hemichannel functionality based on cytosolic uptake of Yo-Pro1

Article Link

Year:

2024

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity

Article Link

Year:

2024

Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Article Link

Year:

2023

In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells

Article Link

Year:

2023

Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine

Article Link

Year:

2023

Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model

Article Link

Year:

2022

Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma

Article Link

Year:

2022

TNF-alpha-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy

Article Link

Year:

2022

Emerging applications of nanobodies in cancer therapy

Article Link

Year:

2022

Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer

Article Link

Year:

2021

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Article Link

Year:

2021

MSH2 knock-down shows CTG repeat stability and concomitant upstream demethylation at the DMPK locus in myotonic dystrophy type 1 human embryonic stem cells

Article Link

Year:

2021

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

Article Link

Year:

2021

Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development

Article Link

Year:

2020

Collaborators (39)

Willem Staels

Vrije Universiteit Brussel

BELGIUM

Sophie Hernot

Vrije Universiteit Brussel

BELGIUM

Katty Zeven

Vrije Universiteit Brussel

BELGIUM

Heleen Hanssens

Vrije Universiteit Brussel

BELGIUM

Ken Maes

Scientist genetic profiling of cancer

BELGIUM

Wout De Mey

Vrije Universiteit Brussel

BELGIUM

Kirsten De Ridder

Vrije Universiteit Brussel

BELGIUM

Cleo Goyvaerts

Vrije Universiteit Brussel

BELGIUM

Geert Raes

Vrije Universiteit Brussel

BELGIUM

Karine Breckpot

Professor

Vrije Universiteit Brussel

BELGIUM

Mathias Van Bulck

Vrije Universiteit Brussel

BELGIUM

Hannelore Ceuppens

Vrije Universiteit Brussel

BELGIUM

Massimiliano Mazzone

Guest Full professor

University of Turin

ITALY

Stephanie Bourgeois

Vrije Universiteit Brussel

BELGIUM

Raf Van Campenhout

Vrije Universiteit Brussel

BELGIUM

axelle cooreman

Vrije Universiteit Brussel

BELGIUM

Robin Maximilian Awad

Vrije Universiteit Brussel

BELGIUM

Luca Tamagnone

Professore Ordinario - Direttore

Università Cattolica del Sacro Cuore

ITALY

Maarten Dewilde

Professor

KU Leuven

BELGIUM

Ann De Becker

Vrije Universiteit Brussel

BELGIUM

Ahmet Krasniqi

Vrije Universiteit Brussel

BELGIUM

Lien De Beck

Vrije Universiteit Brussel

BELGIUM

Sandra Tuyaerts

Vrije Universiteit Brussel

BELGIUM

Matthias D'Huyvetter

Vrije Universiteit Brussel

BELGIUM

HANNE LOCY

Vrije Universiteit Brussel

BELGIUM

Magali Verdonck

Vrije Universiteit Brussel

BELGIUM

Janik Puttemans

Vrije Universiteit Brussel

BELGIUM

Lukasz Mateusiak

Vrije Universiteit Brussel

BELGIUM

Quentin Lecocq

Vrije Universiteit Brussel

BELGIUM

Kim De Veirman

Vrije Universiteit Brussel

BELGIUM

Stefaan Verhulst

Karolinska Institutet

SWEDEN

Alexander Gheldof

Vrije Universiteit Brussel

BELGIUM

Fien Meeus

Vrije Universiteit Brussel

BELGIUM

Thomas Ertveldt

Vrije Universiteit Brussel

BELGIUM

Timo De Groof

Vrije Universiteit Brussel

BELGIUM

Andres Tabernilla

Vrije Universiteit Brussel

BELGIUM

Pieterjan Debie

Vrije Universiteit Brussel

BELGIUM

Bart Neyns

Vrije Universiteit Brussel

BELGIUM

Nick Devoogdt

Vrije Universiteit Brussel

BELGIUM

Yannick De Vlaeminck

Research Interests

Explore related searches

Contact this professor

Articles (16)

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

Scrutiny of chimeric antigen receptor activation by the extracellular domain

Assessment of connexin43 hemichannel functionality based on cytosolic uptake of Yo-Pro1

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity

Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells

Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine

Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model

Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma

TNF-alpha-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy

Emerging applications of nanobodies in cancer therapy

Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

MSH2 knock-down shows CTG repeat stability and concomitant upstream demethylation at the DMPK locus in myotonic dystrophy type 1 human embryonic stem cells

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development

Collaborators (39)

Willem Staels

Sophie Hernot

Katty Zeven

Heleen Hanssens

Ken Maes

Wout De Mey

Kirsten De Ridder

Cleo Goyvaerts

Geert Raes

Karine Breckpot

Mathias Van Bulck

Hannelore Ceuppens

Massimiliano Mazzone

Stephanie Bourgeois

Raf Van Campenhout

axelle cooreman

Robin Maximilian Awad

Luca Tamagnone

Maarten Dewilde

Ann De Becker

Ahmet Krasniqi

Lien De Beck

Sandra Tuyaerts

Matthias D'Huyvetter

HANNE LOCY

Magali Verdonck

Janik Puttemans

Lukasz Mateusiak

Quentin Lecocq

Kim De Veirman

Stefaan Verhulst

Alexander Gheldof

Fien Meeus

Thomas Ertveldt

Timo De Groof

Andres Tabernilla

Pieterjan Debie

Bart Neyns

Nick Devoogdt

How do I reach out?

Meet Kite AI